Royalty Pharma plc - Class A —— 季度财务数据 (NASDAQ:RPRX) | MetaTrader

展开完整图表

Financials

概览声明统计股息

每季度年度

经营活动产生的现金 742.52 M596.08 M363.98 M702.62 M827.15 M 2.49 B 投资活动产生的现金 -505.59 M503.92 M-311.98 M-958.31 M-847.8 M -1.61 B 融资活动产生的现金 -257.96 M-941.3 M-507.81 M562.74 M-299.6 M -1.19 B 自由现金流 742.52 M596.08 M363.98 M702.62 M827.15 M 2.49 B

新闻

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?

Defense Lifts Moat Stocks As Tech Stumbles

Royalty Pharma在TD Cowen会议上展示战略增长洞察

Royalty Pharma at TD Cowen Conference: Strategic Growth Insights

Citizens重申Zymeworks股票评级,基于强劲现金状况

Citizens reiterates Zymeworks stock rating on strong cash position